Arizona Quietly Stopped Fighting Fentanyl. It's Chasing Landscapers Instead.

At 1:51 p.m. on August 16, a 911 call came in from a home in Greenville County, South Carolina: a woman in cardiac arrest. By 2:32 p.m. she was dead. The Greenville County coroner’s office would later confirm what the toxicology already suggested — the actress Hayden Panettiere died of the toxic effects of fentanyl, mixed with four other substances, days after she’d been released from a rehab facility in Malibu. She was 36.

Nothing about that afternoon happened in Arizona. But it’s the reason the state’s own fentanyl numbers matter right now, and why Arizona’s drug seizures — down by more than half since 2023 — have become a political fight instead of a footnote.

Arizona didn’t get safer. It got deprioritized. That’s the accusation at the center of a dispute that broke into public view this week, and the paperwork backs it up more than the administration would like.

The Seizure Numbers Didn’t Just Dip. They Collapsed.

According to Customs and Border Protection’s own statistics, statewide drug seizures in Arizona fell from roughly 27,000 in fiscal year 2023 to just over 10,000 this year — a drop of nearly two-thirds in three years, as first reported by AZFamily. That’s not a rounding error or a seasonal blip. It’s the kind of number that, in any other context, a governor’s office would be holding a press conference about.

The explanation isn’t mysterious, even if the administration hasn’t said it out loud. A Department of Homeland Security Office of Inspector General audit — the agency’s own internal watchdog, not an outside critic — spent fourteen months, from March 2025 to May 2026, examining what happened to the agents who used to do this work. What it found is stark. Homeland Security Investigations, or HSI — the ICE division that builds cases against drug-trafficking networks rather than raiding individual worksites — spent roughly 207,000 hours on immigration enforcement in fiscal year 2024. In fiscal year 2025, that jumped to nearly 2 million hours. Over the same stretch, hours spent on fentanyl investigations fell from about 824,000 to under 570,000. One field office told auditors that 99% of its work was now immigration-related. Fentanyl investigations dropped 24%. Fentanyl seizures fell nearly 40%.

That’s not agents getting outsmarted by cartels. That’s agents getting reassigned.

The Rest of the Country’s Overdose Deaths Are Falling. Arizona’s Are Rising.

Here’s what makes the timing especially bad. Nationally, the CDC’s provisional data shows drug overdose deaths falling for a third straight year — down roughly 12% in the twelve months ending this February. Arizona is going the opposite direction. A study published this month in the journal Drug and Alcohol Dependence, “Despite the decrease in overdose deaths in the United States in 2024, deaths rebound in the State of Arizona in early 2025,” found that provisional overdose deaths in Arizona from January through August 2025 hit 2,034 — a 20% increase over the same stretch in 2024. January through April 2025 were each the highest-death months recorded for those calendar months going back to 2018.

The increases weren’t spread evenly. Deaths involving fentanyl and other synthetic opioids rose 40% year over year. Deaths involving methamphetamine rose 23%. Cocaine-involved deaths rose 66%. Younger Arizonans absorbed the worst of it — deaths among 18-to-24-year-olds climbed 35%, and among 25-to-34-year-olds, 29%. Hispanic Arizonans saw a 43% increase; Non-Hispanic Black Arizonans, 25%.

So while the rest of the country is finally seeing the payoff of years of naloxone distribution, fentanyl test strip access, and medication-assisted treatment expansion, Arizona is trending the other way, at the exact moment federal investigators pulled back from the routes feeding the state’s drug supply. That’s not a coincidence anyone in Washington has had to answer for yet.

Two Officials, Same Data, Opposite Conclusions

Arizona Attorney General Kris Mayes didn’t hedge when AZFamily asked her about it. “The Trump administration calls fentanyl a weapon of mass destruction but has pulled its agents and investigators who are supposed to be dismantling drug rings off their cases to chase landscapers and maids around our cities,” Mayes said. “This is a massive betrayal of every family that has buried a loved one after a fentanyl overdose.”

“This is a massive betrayal of every family that has buried a loved one after a fentanyl overdose.”

It’s worth sitting with what she’s actually claiming, because it’s specific: not that the federal government is failing to stop fentanyl through incompetence, but that it is actively choosing not to, in favor of a different enforcement priority — one that photographs better and produces higher headcount numbers for immigration raids than a months-long wiretap investigation into a trafficking network ever could. An investigation into who’s moving fentanyl through Nogales takes a year and might net a handful of arrests. A worksite sweep takes an afternoon and nets dozens. If you’re being measured by volume, the math makes the choice for you.

If you’re a parent in Phoenix who keeps naloxone — the opioid-overdose reversal medication — in the kitchen drawer because your kid already needed it once, this isn’t an abstract staffing argument. It’s the difference between an agency actively working the supply chain that put the pills in your house, and one that’s somewhere else entirely.

Chris Clem, a retired Border Patrol chief who ran the Yuma sector, reads the same numbers differently in that same AZFamily report. He argued the falling seizure numbers aren’t evidence of neglect — they’re evidence of success further up the supply chain, pointing to diplomatic pressure on the precursor-chemical trade (the raw ingredients, largely manufactured in China and shipped through Mexican labs, that get pressed into counterfeit pills) and other federal agencies picking up narcotics work that used to sit with HSI. There’s a real number that supports at least part of his case: CBP’s own data shows more than 100 million lethal doses of fentanyl seized along the entire southwest border in fiscal year 2026 — a huge figure, driven mostly by seizures outside Arizona. National totals climbing while Arizona’s state-level numbers fall isn’t necessarily a contradiction; it could mean the trafficking routes have shifted, or that other border states and agencies are simply doing more of the work Arizona-based HSI agents used to do.

But “the work is happening somewhere else” is a strange comfort for a state whose overdose deaths remain driven overwhelmingly by illicit fentanyl, and it doesn’t square with the OIG’s own numbers on investigation hours, which measure effort, not just outcome. You can’t diplomatically pressure your way out of 250,000 fewer investigator-hours. Somebody has to actually do that work, and right now, in Arizona, fewer people are.

What Fewer Investigations Do to the Street Supply — and Where This Playbook Comes From

This is the part that gets lost in a fight over spreadsheets: interdiction and investigation aren’t just about seizure totals, they’re about disrupting supply before it fragments into something even more dangerous. The White House’s own drug threat notice from mid-September warns about carfentanil, fluorofentanyl, and methylfentanyl — fentanyl analogues, meaning chemical cousins of fentanyl tweaked just enough to be more potent or harder to detect, with carfentanil alone estimated at up to 100 times more potent than fentanyl itself. That’s what tends to happen when enforcement pressure eases on established routes: the supply doesn’t get safer, it gets more improvised, and improvisation is exactly what’s been driving Arizona’s death toll for a decade. Fewer HSI investigations means fewer disrupted networks, which means less pressure on suppliers to keep their product predictable. It’s a strange thing to have to explain to an administration that describes fentanyl as a weapon of mass destruction: predictability, weirdly, is safer. A known bad supply is survivable in a way an unknown one is not.

This also isn’t the first time resources meant to fight a drug crisis got redirected toward a different, more visible target, and it’s worth naming the precedent. In 1986, Congress passed the Anti-Drug Abuse Act, which punished crack cocaine 100 times more harshly than the pharmacologically near-identical powder cocaine — a gap that had nothing to do with the drug’s danger and everything to do with which neighborhoods were policed hardest. It took until 2010, and the Fair Sentencing Act, to narrow that ratio to 18-to-1, and decades more for anyone in power to admit the enforcement priorities of the 1980s had been chosen for reasons other than public health. Resource allocation in drug policy has never been a neutral technical decision. It’s always also a statement about whose safety the government is optimizing for — and this year’s answer, in Arizona, is measurable in investigator-hours.

It’s always also a statement about whose safety the government is optimizing for — and this year’s answer, in Arizona, is measurable in investigator-hours.

What’s Actually Real Tonight

None of this changes what’s true right now, in Arizona, whatever Washington decides to prioritize next. Naloxone is still free, still legal, and still available through county health departments — Maricopa County’s fentanyl resource hub will point you to where. Fentanyl test strips are still legal to carry in Arizona. The /newsroom/category/arizona-watch beat isn’t going anywhere, and neither is the reporting on what /newsroom/substances/opioids is actually doing to this state, regardless of which federal agency is or isn’t counting it this year.

Kris Mayes is right that redirecting agents doesn’t make fentanyl disappear. Chris Clem is right that a single seizure number doesn’t tell the whole story. Both of those things can be true, and Arizona still ends up with fewer people doing the specific, unglamorous work of taking trafficking networks apart. That’s not a forecast. That’s what the DHS’s own auditors already found, in writing, about the agency’s own agents. Somebody just has to keep saying it out loud.